Pulmonary Circulation, April-June, 2012; Vol 2; Issue 2
Title: Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension
The sentences pertaining should be read as follows
“Conflict of Interest: None declared”
Should read as
“Conflict of Interest: Dr. Barst has been a member of the speakers’ bureau for Actelion Pharmaceuticals US, Inc. and Gilead; has been a consultant and has received honoraria for speaking engagements as an invited speaker for Actelion Pharmaceuticals US, Inc.; Bayer HealthCare Pharmaceuticals; Eli Lilly and Company; Gilead; Ikaria, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; and VentriPoint, Inc.; and is a shareholder of VentriPoint, Inc. stock. Dr. Channick has received grant/research support from and has been a consultant for Ikaria, Inc. and Actelion Pharmaceuticals US, Inc. He has participated in formal advisory activities for Ikaria, Inc.; Actelion Pharmaceuticals US, Inc.; and United Therapeutics Corporation. The University of Colorado receives fees for Dr. Ivy to be a consultant for Actelion Pharmaceuticals US, Inc.; Gilead; Pfizer Inc; and United Therapeutics Corporation. Dr. Goldstein is an employee of Ikaria, Inc.”
The error is regretted
- Chief Editor, PC